Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(11%)

Phase Distribution

Ph phase_3

33%

Ph phase_4

11%

Ph phase_2

44%

Ph not_applicable

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 2Efficacy & side effects

4(44.4%)

Phase 3Large-scale testing

3(33.3%)

Phase 4Post-market surveillance

1(11.1%)

N/ANon-phased studies

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

28.6%

2 of 7 finished

Non-Completion Rate

71.4%

5 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(5)

Other(2)

Detailed Status

Withdrawn4

unknown2

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 24 (44.4%)

Phase 33 (33.3%)

Phase 41 (11.1%)

N/A1 (11.1%)

Trials by Status

unknown222%

terminated111%

completed222%

withdrawn444%

Recent Activity

0 active trials

Showing 5 of 9

withdrawnphase_2

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

NCT00347698

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT00418431Phase 2

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Withdrawn

NCT00406744Phase 3

Efficacy of Retreatments With Intravitreal Bevacizumab

Terminated

NCT00407121Phase 3

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Withdrawn

NCT00406380Phase 3

Effect of Avastin in Juxtafoveal Telangiectasias

Withdrawn

NCT00347698Phase 2

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

Withdrawn

NCT05290948Phase 2

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Unknown

NCT03353324Phase 2

Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion

Unknown

NCT01428388Not Applicable

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion

Completed

NCT01724385Phase 4

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9